1st Quarter - Report

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

Firm
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 296, Preserving Access to Life-Saving Medications Act, all provisions. Contacts concerning Food and Drug Admnistration (FDA)authority to manage drug shortages. Communication to Office of the National Coordinator for Health Information Technology regarding meaningful use implementation. Labor-Health and Human Services Appropriations, fiscal year 2010 and 2011; support for Administration's request for FDA funding. Contacts concerning funding for section 3503 of Affordable Care Act (PL 111-148). Communication to repeal IRS form 1099 reporting provision in Affordable Care Act. S. 48, Pharmacist Student Loan Repayment Eligibility Act, all provisions.

LobbyistCovered position, as disclosed
JOSEPH M HILL —
BRIAN M MEYER —
KAREN NOONAN New —
CHRISTOPHER J TOPOLESKI New —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 48 (112th), S. 296 (112th)

Medicare/Medicaid MMM

Communication with Centers for Medicare and Medicaid Services regarding administration of medication to inpatients within 30 minutes of scheduled dosage time. Communication with CMS regarding Accountable Care Organizations and the Shared Savings Program, Value Based Purchasing Program, and Innovation Center. S. 274, Medication Therapy Management Empowerment Act, all provisions.

LobbyistCovered position, as disclosed
JOSEPH M HILL —
BRIAN M MEYER —
KAREN NOONAN New —
CHRISTOPHER J TOPOLESKI New —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 274 (112th)

Pharmacy PHA

Communication to Surgeon General on recognition of pharmacists as health care providers.

LobbyistCovered position, as disclosed
JOSEPH M HILL —
BRIAN M MEYER —
KAREN NOONAN New —
CHRISTOPHER J TOPOLESKI New —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.